🔎 Trials Near Me

Beranda › Degenerasi Makula › Georgia

Uji klinis Degenerasi Makula di Georgia

6 studi untuk Degenerasi Makula mencari peserta di lokasi di Georgia.

Kota di Georgia

Teks studi resmi (Bahasa Inggris)

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  • Georgia Retina, Marietta
  • Marietta Eye Clinic, Marietta
Menerima pesertaFase 2/3
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06635148

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  • Southeast Retina Center, Augusta
  • Georgia Retina - Marietta, Marietta
Menerima pesertaFase 3
Usia 50 hingga 85 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06541704

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • Emory University Eye Center, Atlanta
Menerima pesertaFase 1
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT03178149

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  • Thomas Eye Group, Sandy Springs
Menerima pesertaFase 3
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT07064759

Active AMD Study to Improve Function in Veterans

  • Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur
Menerima peserta
Usia 65 hingga 89 · Semua jenis kelamin · Diperbarui 23 Feb 2026 · NCT05932069

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

  • CBCC Global Research Site:001, Augusta
Menerima pesertaFase 1
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 7 Feb 2025 · NCT06132035

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.